Aberrant Expression Profiles of lncRNAs and Their Associated Nearby Coding Genes in the Hippocampus of the SAMP8 Mouse Model with AD
- PMID: 32169802
- PMCID: PMC7066064
- DOI: 10.1016/j.omtn.2020.02.008
Aberrant Expression Profiles of lncRNAs and Their Associated Nearby Coding Genes in the Hippocampus of the SAMP8 Mouse Model with AD
Abstract
The senescence-accelerated mouse prone 8 (SAMP8) mouse model is a useful model for investigating the fundamental mechanisms involved in the age-related learning and memory deficits of Alzheimer's disease (AD), while the SAM/resistant 1 (SAMR1) mouse model shows normal features. Recent evidence has shown that long non-coding RNAs (lncRNAs) may play an important role in AD pathogenesis. However, a comprehensive and systematic understanding of the function of AD-related lncRNAs and their associated nearby coding genes in AD is still lacking. In this study, we collected the hippocampus, the main area of AD pathological processes, of SAMP8 and SAMR1 animals and performed microarray analysis to identify aberrantly expressed lncRNAs and their associated nearby coding genes, which may contribute to AD pathogenesis. We identified 3,112 differentially expressed lncRNAs and 3,191 differentially expressed mRNAs in SAMP8 mice compared to SAMR1 mice. More than 70% of the deregulated lncRNAs were intergenic and exon sense-overlapping lncRNAs. Gene Ontology (GO) and pathway analyses of the AD-related transcripts were also performed and are described in detail, which imply that metabolic process reprograming was likely related to AD. Furthermore, six lncRNAs and six mRNAs were selected for further validation of the microarray results using quantitative PCR, and the results were consistent with the findings from the microarray. Moreover, we analyzed 780 lincRNAs (also called long "intergenic" non-coding RNAs) and their associated nearby coding genes. Among these lincRNAs, AK158400 had the most genes nearby (n = 13), all of which belonged to the histone cluster 1 family, suggesting regulation of the nucleosome structure of the chromosomal fiber by affecting nearby genes during AD progression. In addition, we also identified 97 aberrant antisense lncRNAs and their associated coding genes. It is likely that these dysregulated lncRNAs and their associated nearby coding genes play a role in the development and/or progression of AD.
Keywords: Alzheimer’s disease; lncRNA-associated nearby genes; lncRNAs.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Figures










Similar articles
-
Systematic Analysis of Long Noncoding RNAs in the Senescence-accelerated Mouse Prone 8 Brain Using RNA Sequencing.Mol Ther Nucleic Acids. 2016 Aug 2;5(8):e343. doi: 10.1038/mtna.2016.57. Mol Ther Nucleic Acids. 2016. PMID: 27483026 Free PMC article.
-
Long Non-coding RNA Signatures Associated With Liver Aging in Senescence-Accelerated Mouse Prone 8 Model.Front Cell Dev Biol. 2021 Jul 22;9:698442. doi: 10.3389/fcell.2021.698442. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34368149 Free PMC article.
-
Changes in Gene Expression Profile with Age in SAMP8: Identifying Transcripts Involved in Cognitive Decline and Sporadic Alzheimer's Disease.Genes (Basel). 2024 Oct 31;15(11):1411. doi: 10.3390/genes15111411. Genes (Basel). 2024. PMID: 39596610 Free PMC article.
-
Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.Brain Res Bull. 2013 Aug;97:69-80. doi: 10.1016/j.brainresbull.2013.06.001. Epub 2013 Jun 10. Brain Res Bull. 2013. PMID: 23756188 Review.
-
The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease.Exp Gerontol. 2005 Oct;40(10):774-83. doi: 10.1016/j.exger.2005.05.007. Epub 2005 Jul 18. Exp Gerontol. 2005. PMID: 16026957 Review.
Cited by
-
A promising drug repurposing approach for Alzheimer's treatment: Givinostat improves cognitive behavior and pathological features in APP/PS1 mice.Redox Biol. 2024 Dec;78:103420. doi: 10.1016/j.redox.2024.103420. Epub 2024 Nov 6. Redox Biol. 2024. PMID: 39577323 Free PMC article.
-
Long Non-Coding RNA (lncRNA) Roles in Cell Biology, Neurodevelopment and Neurological Disorders.Noncoding RNA. 2021 Jun 17;7(2):36. doi: 10.3390/ncrna7020036. Noncoding RNA. 2021. PMID: 34204536 Free PMC article. Review.
-
Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease.Front Neurol. 2020 Oct 15;11:538301. doi: 10.3389/fneur.2020.538301. eCollection 2020. Front Neurol. 2020. PMID: 33178099 Free PMC article. Review.
-
Microalgae Aurantiochytrium Sp. Increases Neurogenesis and Improves Spatial Learning and Memory in Senescence-Accelerated Mouse-Prone 8 Mice.Front Cell Dev Biol. 2021 Feb 9;8:600575. doi: 10.3389/fcell.2020.600575. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33634096 Free PMC article.
-
Sustained Depolarization Induces Gene Expression Pattern Changes Related to Synaptic Plasticity in a Human Cholinergic Cellular Model.Mol Neurobiol. 2025 Jan;62(1):935-945. doi: 10.1007/s12035-024-04262-w. Epub 2024 Jun 28. Mol Neurobiol. 2025. PMID: 38941065 Free PMC article.
References
-
- Yaari R., Corey-Bloom J. Alzheimer’s disease. Semin. Neurol. 2007;27:32–41. - PubMed
-
- Jaroudi W., Garami J., Garrido S., Hornberger M., Keri S., Moustafa A.A. Factors underlying cognitive decline in old age and Alzheimer’s disease: the role of the hippocampus. Rev. Neurosci. 2017;28:705–714. - PubMed
-
- Anand R., Gill K.D., Mahdi A.A. Therapeutics of Alzheimer’s disease: past, present and future. Neuropharmacology. 2014;76:27–50. - PubMed
-
- Zhang C., Du Q.Y., Chen L.D., Wu W.H., Liao S.Y., Yu L.H., Liang X.T. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer’s disease. Eur. J. Med. Chem. 2016;116:200–209. - PubMed
LinkOut - more resources
Full Text Sources